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ABSTRACT
Lannea acida is widely used as herbal medicine in West Africa. The present study critically reviewed the medicinal uses and phytochemistry and 
pharmacological properties of L. acida. The keywords including L. acida, its synonyms, English common names, medicinal uses, and phytochemistry 
and pharmacological properties of the species were searched using electronic databases such as ISI web of knowledge, ProQuest, ScienceDirect, 
OATD, Scopus, OpenThesis, PubMed, and Google Scholar. The search for pre-electronic literature such as conference papers, scientific articles, 
books, book chapters, dissertations, and theses was carried out at the university library. Literature studies revealed that L. acida is mainly used for 
injuries, inflammation and pain, gastrointestinal problems, fever and malaria, gynecological and pregnancy disorders, ethnoveterinary medicine, 
hemorrhoids, skin diseases, and infections. Phytochemical compounds identified from the species include alkaloids, cardiac glycosides, flavonoids, 
phenols, saponins, steroids, tannins, and terpenoids. Pharmacological studies revealed that L. acida extracts have anthelmintic, antibacterial, 
antidiarrheal, anti-inflammatory, antimycobacterial, antioxidant, estrogenic, fertility, hyaluronidase, phospholipase A2, proteolytic, and vibriocidal 
activities. Given the importance of L. acida as herbal medicine, there is a need for detailed studies aimed at establishing the efficacy, clinical relevance, 
and safety of the plant extracts and compounds.
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INTRODUCTION
Lannea acida A. Rich. belongs to the cashew or Anacardiaceae family. 
The name of the genus, “Lannea,” is based on a Latin word “lana” 
which translates to “wool” in reference to young plant parts which 
are densely hairy or possibly to the wool on the roots of some Lannea 
species [1,2]. The synonyms of L. acida are Lannea buettneri Engl., 
Lannea djalonica A. Chev., Lannea glaucescens Engl., Lannea lagdoensis 
(Engl. and K. Krause) Mildbr., Lannea oleosa A. Chev., Odinaacida 
(A. Chev.) Walp., and Sorindeia lagdoensis Engl. and K. Krause [3-6]. 
The genus Lannea consists of approximately 40 species which are 
usually trees, shrubs, or suffrutices, occupying different habitats in 
Sub-Saharan Africa, with only one species recorded in Tropical Asia 
and several species introduced throughout the world [4-6]. L. acida 
is a multipurpose tree indigenous to Benin, Burkina Faso, Cameroon, 
Central African Republic, Côte d’Ivoire, Gambia, Ghana, Guinea, Mali, 
Niger, and Nigeria [3,7-13]. The species has been recorded in wooded 
savannah, forest edges, bushed grassland, rocky outcrops, and near 
Riverson sandy soils at an altitude ranging from 0 to 1600 m above sea 
level [13]. The tree species is widely used by local communities in West 
Africa as a source of dye, food, medicines, and other commodities. Its 
berry-like fruits which are about 1 cm across and 1.5 cm long occur in 
large clusters and are consumed either fresh or dried and can be stored 
for use months later [14]. The fruits have a slightly acidic and somewhat 
resinous, pleasant taste, and both fresh and dried fruits are eaten raw 
or made into juice, jam, and puddings [14]. The young leaves of L. acida 
are cooked as leafy vegetables [13]. In clearing land for agricultural 
purposes, some communities in West Africa do not cut L. acida, thereby 
ensuring a continued supply of goods and ecosystem services provided 
by the species [13]. In Senegal, L. acida is regarded as an important 
herbal medicine, with different plant parts sold on informal herbal 
medicine markets [13]. Marquet and Jansen [15] identified L. acida 
as an important useful plant species with domestication potential in 
West Africa based on its multipurpose uses and popularity as herbal 
medicine. It is within this context that this review was undertaken 
aimed to summarize the medicinal uses and phytochemical and 
pharmacological properties of L. acida so as to provide baseline data 
required for evaluating the therapeutic potential of the species.
MEDICINAL USES OF L. ACIDA
The major documented diseases and ailments treated by L. acida 
extracts were grouped and classified following the guidelines provided 
by Cook [16] and Gruca et al. [17] (Table 1). The major medicinal 
uses of L. acida (in descending order of importance) include injuries, 
inflammation and pain, gastrointestinal problems, fever and malaria, 
gynecological and pregnancy disorders, ethnoveterinary medicine, 
haemorrhoids, skin diseases, and infections (Fig. 1). In multitherapeutic 
applications, the bark of L. acida is applied topically for swellings mixed 
with cloves of Parkia biglobosa (Jacq.) R. Br. ex G. Don, while the leaves 
of L. acida are mixed with leaves and roots of Alafia barteri Oliv. and 
Flueggea virosa (Roxb. ex Willd.) Royle and pods of Xylopia aethiopica 
(Dunal) A. Rich. as herbal medicine for cancer [18]. In Ghana, the 
leaves of L. acida are mixed with those of Azadirachta indica A. Juss. 
and Mangifera indica L. as herbal medicine for malaria [19]. The bark 
of L. acida is mixed with that of Guiera senegalensis J. F. Gmel as herbal 
medicine for intestinal parasites [20], while bark mixed with different 
plant parts of Euphorbia unispina N. E. Br. are used against new castle 
disease [21]. In Benin, the roots of L. acida are mixed with the bark 
of Detarium microcarpum Guill. and Perr. and Khaya senegalensis 
(Desv.) A. Juss. and used as ethnoveterinary medicine against foot and 
mouth [21].
PHYTOCHEMISTRY AND PHARMACOLOGICAL PROPERTIES 
OF L. ACIDA
Sultana and Ilyas [51] identified a flavanone, 6,7-(2”,2”-dimethyl 
chromeno)-8-γ,γ-dimethyl allyl flavanone1 (Fig. 2) from the 
acetone extract of L. acida leaves using nuclear magnetic 
resonance (NMR) and ultraviolet-visible spectroscopy. Similarly, 
Muhaisen [52] identified four flavonoids which included 
6,7-(2”,2”-dimethyl chromeno)-8-γ,γ-dimethyl allyl flavanone 1, 
© 2018 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2018.v11i11.28813
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3’,4’dihydroxy-7,8  (2”,2”dimethyl  chromeno)-6γ,γ-dimethyl  allyl 
flavonol 2, 7-methyltectorigenin 3, and irisolidone 4 (Fig. 2) from 
the bark of L. acida using NMR, UV, infrared, and mass spectrometry. 
Flavonoids are characterized by several pharmacological properties, 
for example, irisolidone 4 is known to possess anti-Helicobacter 
pylori activities [53], inhibition of prostaglandin E2 production 
[54], hepatoprotective activities [55,56], cancer chemopreventive 
activities [57], estrogenic activities [58], inhibitory effect of JC1 
virus gene expression [59], anti-inflammatory activities [60,61], and 
protective properties against hydrogen peroxide (H2O2) [62]. Other 
phytochemical compounds identified from the bark and stem bark 
of L. acida include alkaloids, cardiac glycosides, phenols, saponins, 
steroids, tannins, and terpenoids [37,41,63-65]. Leung et al. [66] 
analyzed the calcium, carbohydrates, energy, fat, fiber, phosphorous, 
and protein content of L. acida leaves as a means of estimating the 
quality of leaves as vegetable sources (Table 2).
The pharmacological activities exhibited by L. acida extracts 
include the following: Anthelmintic [25], antibacterial [24,67], 
antidiarrheal [37], anti-inflammatory [64], antimycobacterial [34], 
antioxidant [65,67], estrogenic [41], fertility [68], hyaluronidase [48,69], 
phospholipase A2 [48,69], proteolytic [48,69], and vibriocidal [70] 
activities.
Anthelmintic activities
Kone et al. [25] evaluated the anthelmintic activities of ethanol stem 
bark extract of L. acida using the nematode Haemonchus contortus 
Rudolphi as the test species and ivermectin and fenbendazole, 
commercial anthelmintics as positive controls by determining the 
number of unhatched eggs and the number of larvae, the developmental 
stages of larvae, and their mobility. The extract exhibited larvicidal 
concentration (LC100) value of 0.8 mg/ml, while ivermectin and 
fenbendazole exhibited LC100 values of 0.001 mg/ml and 0.01 mg/ml, 
Table 1: Medicinal uses of Lannea acida
Medicinal use Parts of the plant used Country References
Injuries, inflammation, and 
pain (abdominal pain, burns, furuncle, 
gout, rheumatism, swellings, toothache, 
ulcers, and wounds)
Bark, leaves, roots, and stem bark Benin, Burkina Faso, Côte 
d’Ivoire, Gambia, Mali, 
Nigeria, and Senegal
[3,13,22-28]
Swellings Bark mixed with cloves of Parkia 
biglobosa (Jacq.) R. Br. ex G. Don
Benin [29]
Anemia Stem bark Côte d’Ivoire [24]
Blood tonic Bark Nigeria [30]
Cancer Stem bark Nigeria [31]
Cancer Leaves mixed with leaves and roots 
of Alafia barteri Oliv. and Flueggea 
virosa (Roxb. ex Willd.) Royle and pods of 
Xylopia aethiopica (Dunal) A. Rich.
Nigeria [18]
Consciousness loss Bark, leaves, and roots Burkina Faso [32]
Convulsions Whole plant Ghana [33]
Cough Bark, leaves, and roots Burkina Faso [34]
Diabetes Whole plant Guinea [35]
Gastrointestinal problems (abdominal 
bloating, constipation, diarrhea, 
dysentery, and stomach ache)
Bark, leaves, roots, and stem bark Burkina Faso, Cameroon, 
Côte d’Ivoire, Niger, and 
Nigeria
[24,25,27,28,34,36-41]
Epilepsy Bark, leaves, and roots Burkina Faso [32]
Epistaxis Stem bark Burkina Faso [42]
Eye problems Bark Nigeria [27]
Gynecological and pregnancy 
disorders (facilitate labor, infertility, 
gynecological complaints, and 
menstrual pain)
Bark and stem bark Burkina Faso, Cameroon, 
Nigeria, and Senegal
[13,27,41,42]
Fever and malaria Bark, leaves, roots, and stem bark Benin, Burkina Faso, and 
Nigeria
[3,34,42-44]
Malaria Leaves mixed with those of Azadirachta 
indica A. Juss. and Mangifera indica L.
Ghana [19]
General well-being Bark Nigeria [45]
Gonorrhea Roots and stem bark Côte d’Ivoire [24]
Hemorrhoids Bark and leaves Burkina Faso, Niger, and 
Nigeria
[39,40,46]
Hallucination Bark, leaves, and roots Burkina Faso [32]
Headache Stem bark Burkina Faso [42]
Intestinal worms Bark and leaves Niger [40]
Mycosis Bark Burkina Faso [39]
Skin diseases and infections Bark, leaves, roots, and stem bark Burkina Faso and Nigeria [34,36,42,47]
Snakebite Cortex Mali [48]
Ethnoveterinary medicine (internal 
parasites and new castle)
Bark Benin and Burkina Faso [49,50]
Intestinal parasites Bark mixed with that of Guiera 
senegalensis J. F. Gmel
Cameroon [20]
Foot and mouth Root mixed with the bark of Detarium 
microcarpum Guill. and Perr. and Khaya 
senegalensis (Desv.) A. Juss.
Benin [21]
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respectively [25]. The anthelmintic activities exhibited by the species 
corroborate the traditional usage of the bark and leaves of L. acida 
against intestinal worms in Niger [40] and as ethnoveterinary medicine 
against intestinal parasites in Cameroon [20].
Antidiarrheal activities
Etuk et al. [37] evaluated the antidiarrheal activities of the aqueous 
bark extract of L. acida using the castor oil model of diarrhea induction 
in Wistar rats with diphenoxylate as a standard antidiarrheal agent. The 
oral administration of 200 mg/kg of the extracts exhibited inhibition 
against castor oil-induced diarrhea in rats [37]. These results show that 
L. acida extracts have potential in the management of gastrointestinal 
problems such as abdominal bloating, constipation, diarrhea, dysentery, 
and stomach ache [24,25,27,28,34,36-41]. Research by Stark et al. [71] 
and Maroyi [72] showed that medicinal plants have potential in the 
treatment of gastrointestinal disorders and the pain that is associated 
with the disorders.
Antibacterial activities
Kone et al. [24] evaluated antibacterial activities of ethanol root 
extracts of L. acida against Escherichia coli, Pseudomonas aeruginosa, 
Staphylococcus aureus, Enterococcus faecalis, Streptococcus pyogenes, 
and Bacillus subtilis using agar diffusion and microdilution methods 
with gentamicin and tetracycline as positive controls. The extracts 
were active against S. aureus, E. faecalis, and S. pyogenes with minimum 
inhibitory concentration (MIC) values ranging from 23 µg/ml to 
1500 µg/ml and half maximal inhibitory concentration (IC50) values 
ranging from 94 µg/ml to 188 µg/ml. The MIC values exhibited by 
the two controls ranged from 0.2 µg/ml to >50 µg/ml and IC50 values 
ranged from 25 µg/ml to 50 µg/ml [24]. Ouattara et al. [67] evaluated 
antibacterial activities of ethanol bark extracts of L. acida against 
Bacillus subtilus, Enterobacter aerogenes, E. faecalis, Proteus mirabilis, P. 
aeruginosa, Salmonella enterica, Salmonella typhimurium, S. aureus, and 
Staphylococcus camorum using disc diffusion and broth microdilution 
methods with ciprofloxacin, erythromycin, and tetracycline as positive 
controls. The extracts exhibited activities against all tested pathogens 
except E. aerogenes with 11–17 mm zone of inhibition. The extracts 
were active against most pathogens except S. typhimurium with MIC 
values ranging from 7.8 to 125.0 µg/mL and minimum bactericidal 
concentration values ranging from 15.6 to >500.0 µg/mL [67]. These 
antibacterial activities exhibited by the extracts of L. acida support the 
traditional usage of the species as remedy for bacterial pathogens causing 
diarrhea [24,25,27,34,37,39,41], dysentery [25,34,38,40], furuncle [28], 
gonorrhea [24], microbial infections on burns and wounds [3,22,23], 
skin infections [36], stomach ache [24,28,36,38,39,40], and 
toothache [13,26].
Anti-inflammatory activities
Owusu and Ofori-Amoah [64] evaluated anti-inflammatory activities of 
aqueous stem bark extract of L. acida using paw edema and writhing 
test assays in male Sprague Dawley rats. The extract at 30–300 mg/kg 
reduced prostaglandin E2-induced paw edema in both prophylactic and 
curative protocols. The extract also significantly inhibited acetic acid-
induced abdominal writhing movement in imprint control region mice. 
In the prophylactic protocol, at 30 mg/kg, the percentage total inhibitory 
effects of the extract were 68.4%, while in the curative protocol, the 
percentage maximal inhibitory effects of the extract at 300 mg/kg were 
67.1%. The extracts inhibited prostaglandin E2-induced paw edema and 
acetic acid-induced writhing movements in animal models and, therefore, 
are potential remedies for inflammation and pain [64], corroborating 
the traditional usage of the species against rheumatism [3,22,24], 
swellings [3,22,29], ulcers [27], and wounds [3,22,23].
Antimycobacterial activities
Ouattara et al. [34] evaluated antimycobacterial activities of ethanol-
water bark extract of L. acida using the anti-Mycobacterium tuberculosis 
Fig. 1: Main medicinal uses of Lannea acida in West Africa
Fig. 2: Chemical structures of flavonoids identified from the bark 
and leaves of Lannea acid
Table 2: Nutritional composition of fruits and other plant parts of bark, leaves, and stem bark of Lannea acida
Caloric and nutritional composition Values Plant parts References
Alkaloids (mg equivalent berberine/g dry weight) 31.6±5.6 Bark [41]
Total flavonoids (mg GAE/100 g lyophilized extract) 87–250 Bark [41,67]
Total phenolics (g GAE/100 g lyophilized extract) 15.1–40.6 Bark and stem bark [41,65,67]
Energy value (kJ per 100 g) 69.0 Leaves [66]
Moisture (% of dry weight) 79.0 Leaves [66]
Fat (% of dry weight) 4.0 Leaves [66]
Protein (% of dry weight) 3.4 Leaves [66]
Carbohydrates (% of dry weight) 14.0 Leaves [66]
Fiber (% of dry weight) 2.2 Leaves [66]
Ash (% of dry weight) 1.0 Leaves [66]
Calcium (g/100 g) 187.0 Leaves [66]
Phosphorus (mg/100 g) 63.0 Leaves [66]
GAE: Gallic acid equivalent
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assay against M. tuberculosis H37Rv. The percentage of inhibition 
of M. tuberculosis proliferation was 77.6% and 36.8% at 1.2 and 
0.6 mg/mL, respectively [34]. These documented antimycobacterial 
activities of L. acida extracts which support the medicinal uses of the 
species in the treatment of respiratory system disorders including 
cough in Burkina Faso [34].
Antioxidant activities
Ouattara et al. [67] evaluated antioxidant activities of ethanol bark 
extracts of L. acida using the 2,2’-diphenyl-1-picrylhydrazyl (DPPH) free 
radical scavenging assay with gallic acid and quercetin as positive controls. 
The extract exhibited IC50 value of 345.7 µg/mL, while the controls, gallic 
acid and quercetin exhibited much lower IC50 values of 0.6 µg/mL and 
0.9 µg/mL, respectively [67]. Onoshe et al. [65] evaluated the antioxidant 
activities of ethyl acetate stem bark extracts of L. acida using the DPPH 
free radical scavenging assay with ascorbic acid as control. The extract 
exhibited the highest percentage scavenging activity of 90% at a 
concentration of 20 mg/mL which was comparable to scavenging activity 
exhibited by ascorbic acid, although the scavenging activity of the control 
was relatively more pronounced than that of the extract at 2.5 mg/mL, 
5 mg/mL, and 10 mg/mL [65]. The antioxidant activities exhibited by 
L. acida extracts are probably due to flavonoids and phenolics that have 
been identified from the species [41,51,52,65,67], and flavonoids and 
phenolics are known to exhibit antioxidant properties [73-81].
Estrogenic activities
Oumarou et al. [41] evaluated the estrogenic activities of bark ethanolic 
extracts of L. acida using a 3-day uterotrophic assay and a 12-week 
oral treatment in ovariectomized adult female Wistar rats. To evaluate 
estrogenic-like effects of L. acida extracts, a simple and sensitive 
E-screen cell proliferation assay was performed with MCF-7 cells. 
The 3-day oral administration of bark extracts induced an increase in 
uterine wet weight, uterine water content, uterine total protein and 
glycogen levels, uterine and vaginal epithelial heights, and mammary 
glands differentiation. At 200 mg/kg, a long-term treatment with the 
extract prevented body weight gain and loss of bone mass and/or 
density induced by ovariectomy [41]. L. acida extract improved bone 
microarchitecture and could restore normal bone mineralization by 
increasing the inorganic phosphorus and calcium level in bone. The 
L. acida ethanol extract induced a significant increase of MCF-7 cells 
yield at concentrations of 10 µg/mL, 100 µg/mL, and 200 µg/mL as 
compared to DMSO control [41]. Taken altogether, this finding provides 
the evidence that L. acida is a potential alternative for the prevention 
of postmenopausal osteoporosis which occurs as a consequence of 
estrogen decline at menopause [41].
Fertility activities
Ahmed et al. [68] evaluated the effect of methanolic stem bark extract 
of L. acida on sperm count, sperm motility, sperm morphology, serum 
testosterone, and histology of the testes on male Wistar rats. Results 
of this study showed that the administration of the stem bark extract 
of L. acida increased sperm count, morphology, motility, and serum 
testosterone levels in Wistar rats [68].
Hyaluronidase activities
Molander et al. [48] evaluated the hyaluronidase activities of aqueous 
and ethanol cortex extracts of L. acida using the hyaluronidase assay 
with aristolochic acid as a positive control and Bitis arietans and 
Naja nigricollis as enzyme sources. The aqueous and ethanol extracts 
exhibited inhibition of 64% and 111%, respectively, where B. arietans 
was used as an enzyme source and 101% and 136% where N. nigricollis 
was used. Both the extracts exhibited IC50 values of 0.1 mg/ml. 
The ethanol extract exhibited an IC50 value of 0.08 after removal of 
polyphenols [48]. Molander et al. [69] also evaluated aqueous and 
ethanol cortex extracts of L. acida in an ex vivo air-liquid interface 
model, and a wound healing scratch assay as well as for their ability 
to permeate the skin barrier and inhibit venom-induced cell death. 
The extracts were not able to lower the cell toxicity of the venom and 
showed no effect against cell death and tissue damage [69].
Phospholipase A2 activities
Molander et al. [48] evaluated the phospholipase A2 activities of 
aqueous and ethanol cortex extracts of L. acida using the phospholipase 
A2 activity assay with ethylenediaminetetraacetic acid (EDTA) as a 
positive control and B. arietans as an enzyme source. The aqueous and 
ethanol extracts exhibited inhibition of 137% and 122%, respectively, 
and IC50 values of 0.2 mg/ml and 0.1 mg/ml. The ethanol extract 
exhibited an IC50 value of 0.2 after the removal of polyphenols [48]. 
Molander et al. [69] also evaluated aqueous and ethanol cortex extracts 
of L. acida in an ex vivo air-liquid interface model and a wound healing 
scratch assay as well as for their ability to permeate the skin barrier and 
inhibit venom-induced cell death. The extracts were not able to lower 
the cell toxicity of the venom and showed no effect against cell death 
and tissue damage [69].
Proteolytic activities
Molander et al. [48] evaluated the protease activities of aqueous and 
ethanol cortex extracts of L. acida using casein as substrate according 
to the method of Satake et al. [82] adjusted to microtiter plates with 
4-(2-aminoethyl)benzenesulfonyl fluoride and EDTA as positive 
controls and B. arietans as an enzyme source. The aqueous and ethanol 
extracts exhibited inhibition of 102% and 86%, respectively, while 
aqueous extract exhibited IC50 value of 0.2 mg/ml [48]. Molander 
et al. [69] also evaluated aqueous and ethanol cortex extracts of L. acida 
in an ex vivo air-liquid interface model and a wound healing scratch 
assay as well as for their ability to permeate the skin barrier and inhibit 
venom-induced cell death. The extracts were not able to lower the cell 
toxicity of the venom and showed no effect against cell death and tissue 
damage [69].
Vibriocidal activities
Akinsinde and Olukoya [70] evaluated vibriocidal activities of aqueous 
and ethanol stem extracts of L. acida against Vibrio cholerae using 
agar diffusion method with streptomycin as control. The extracts 
showed moderate activities with a zone of inhibition ranging from 5 
to 15 mm [70]. These antibacterial activities exhibited by extracts 
of L. acida support the traditional usage of the plant as a remedy for 
diarrhea in Cameroon Burkina Faso [34,39], Cameroon [41], Côte 
d’Ivoire [24,25], and Nigeria [27,37].
CONCLUSION
L. acida is an important herbal medicine in West Africa, and there are still 
some research gaps in the phytochemical and pharmacological analyses 
of the crude extracts of the species as well as compounds isolated 
from the species. There is a need to correlate the medicinal uses of the 
species with the chemical compounds and pharmacological properties 
of the compounds and extracts of the species. Detailed research on 
pharmacokinetics, in vivo, and clinical research involving compounds 
isolated from L. acida and extracts of the species are required. Future 
research should also focus on the toxicological properties of the 
compounds isolated from the species as well as its crude extracts. Since 
L. acida is used in combination with other plant species in various herbal 
concoctions, it is important to evaluate the synergistic effects of the 
different extracts and their ability to enhance the efficiency of the additive 
mixtures. Detailed phytochemical, pharmacological, and toxicological 
studies will enable researchers to evaluate the therapeutical importance 
of the species in tropical Africa [83,84].
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